NCT06351917

Effect of Topical PlexoZome® Levagen® Spray on Relief of Post Exercise Knee Joint Pain

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 80 (actual)
• Sponsor: RDC Clinical Pty Ltd · Industry
• Sex: All
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

This is a randomised, double-blind, placebo controlled, 2 arm parallel clinical trial to evaluate the effect of topical PlexoZome® Levagen® spray on relief of post exercise knee joint pain in healthy adults compared to placebo over 4 weeks duration.

Conditions

• Knee Joint Pain

Interventions

Type	Name	Description
DRUG	PlexoZome® Levagen® topical spray solution	PlexoZome® Levagen® topical spray solution 10mg/g providing 1.8mg active per pump
DRUG	Placebo topical spray solution	Placebo topical spray solution topical spray solution 0mg/g providing 0mg active per pump

Timeline

• Start date: 2024-04-24
• Primary completion: 2024-06-18
• Completion: 2024-06-18
• First posted: 2024-04-08
• Last updated: 2024-12-05

Locations

1 site across 1 country: Australia